Canaan
CAN
The9 Ltd
NCTY
Intchains Group
ICG
Digihost Technology
DGHI
BIT Mining
BTCM
US Stock MarketDetailed Quotes
SNDX Syndax Pharmaceuticals
- 13.260
- -0.470-3.42%
Trading Mar 25 15:35 ET
1.14BMarket Cap-3.56P/E (TTM)
13.765High13.230Low436.93KVolume13.760Open13.730Pre Close5.84MTurnover0.57%Turnover RatioLossP/E (Static)86.02MShares25.07052wk High3.96P/B1.02BFloat Cap12.06052wk Low--Dividend TTM77.18MShs Float29.860Historical High--Div YieldTTM3.90%Amplitude3.390Historical Low13.355Avg Price1Lot Size
Syndax Pharmaceuticals Key Stats
EPS
According to the latest financial report of Syndax Pharmaceuticals, the latest earnings per share (TTM) for the company is -1.10. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Syndax Pharmaceuticals's free cash flow? The latest report shows it as -57.39M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Syndax Pharmaceuticals shows that the company's current ratio is 5.82, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Syndax Pharmaceuticals, the quick ratio is 5.76, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Syndax Pharmaceuticals? The latest ROE figure is -28.77%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Syndax Pharmaceuticals, the total asset return on investment (ROA) is -16.37%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Syndax Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Syndax Pharmaceuticals, the net profit margin is -1.23K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.